Building a Measure of Fatigue: The Functional Assessment of Chronic Illness Therapy Fatigue Scale

PM and R

Volumn 2, Issue 5, 2010, Pages 359-363

  Smith, Eleanor ^a   Lai, Jin Shei ^b   Cella, David ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ECULIZUMAB; ETANERCEPT; PLACEBO; RITUXIMAB;

ACCURACY; ANEMIA; ARTHRALGIA; ARTICLE; CLINICAL ASSESSMENT TOOL; DRUG EFFICACY; FATIGUE; FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY FATIGUE SCALE; HUMAN; NEOPLASM; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RELIABILITY; SCORING SYSTEM; SELF REPORT; TREATMENT RESPONSE; VALIDITY;

CHRONIC DISEASE; FATIGUE; HEALTH STATUS INDICATORS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS;

EID: 77952850297     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2010.04.017     Document Type: Article

References (23)

1. World Health Organization. International Classification of Functioning, Disability and Health (ICF) (2001), World Health Organization, Geneva, Switzerland
2. Glaus A. Fatigue: an orphan topic in patients with cancer?. Eur J Cancer 34 (1998) 1649-1651
3. North American Nursing Diagnosis Association. Nursing Diagnoses: Definition and Classification, 1997-1998 (1996), McGraw-Hill, Philadelphia, PA
4. Leavitt V.M., and DeLuca J. Central Fatigue: Issues related to cognition, mood and behavior, and psychiatric dagnoses. PM&R 2 (2010) 332-337
5. Yellen S.B., Cella D.F., Webster K., Blendowski C., and Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 13 (1997) 63-74
6. Cella D., Zagari M.J., Vandoros C., Gagnon D.D., Hurtz H.J., and Nortier J.W. Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population. J Clin Oncol 21 (2003) 366-373
7. Cella D., Lai J.S., Chang C.H., Peterman A., and Slavin M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 94 (2002) 528-538
8. Crane P., Gibbons L., Narasimhalu K., Lai J.S., and Cella D. Rapid detection of differential item functioning in assessments of health-related quality of life: the Functional Assessment of Cancer Therapy. Qual Life Res 16 (2007) 101-114
9. Hahn E.A., Cella D., Dobrez D.G., et al. The impact of literacy on health-related quality of life measurement and outcomes in cancer outpatients. Qual Life Res 16 (2007) 495-507
10. Hahn E.A., Rao D., Cella D., and Choi S.W. Comparability of interview- and self-administration of the Functional Assessment of Cancer Therapy-General (FACT-G) in English- and Spanish-speaking ambulatory cancer patients. Med Care 46 (2008) 423-431
11. Mallinson T., Cella D., Cashy J., and Holzner B. Giving meaning to measure: linking self-reported fatigue and function to performance of everyday activities. J Pain Symptom Manage 31 (2006) 229-241
12. Brown D.J.F., McMillan D.C., and Milroy R. The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Cancer 103 (2005) 377-382
13. Berndt E., Kallich J., McDermott A., Xu X., Lee H., and Glaspy J. Reductions in anemia and fatigue are associated with improvements in productivity in cancer patients receiving chemotherapy. Pharmacoeconomics 23 (2005) 505-514
14. Dahele M., Skipworth R.J., Wall L., Voss A., Preston T., and Fearon K.C. Objective physical activity and self-reported quality of life in patients receiving palliative chemotherapy. J Pain 33 (2007) 676-685
15. Tyring S., Gottlieb A., Papp K., et al. Etanercept improves clinical outcomes, fatigue and symptoms of depression in subjects with psoriasis: results from a double-blind placebo-controlled, randomized phase 3 study. Lancet 367 (2006) 29-35
16. Cohen E.E. Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol 24 (2006) 2659-2665
17. Gladman D.D., Mease P.J., Cifaldi M.A., Perdok R.J., Sasso E., and Medich J. Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial. Ann Rheum Dis 66 (2007) 163-168
18. Hillmen P., Young N.S., Schubert J., et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 355 12 (2006) 1233-1243
19. Brucker P.S., Yost K., Cashy J., Webster K., and Cella D. General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Eval Health Prof 28 (2005) 192-211
20. Lai J.S., Cella D., Chang C.H., Bode R.K., and Heinemann A.W. Item banking to improve, shorten and computerize self-reported fatigue: an illustration of steps to create a core item bank from the FACIT-Fatigue Scale. Qual Life Res 12 (2003) 485-501
21. Fries J.F., Bruce B., and Cella D. The promise of PROMIS: using item response theory to improve assessment of patient-reported outcomes. Clin Exp Rheumatol 23 (2005) S33-S37
22. Cella D., Yount S., Rothrock N., et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap Cooperative Group during its first two years. Med Care 45 Suppl 1 (2007) S3-S11
23. Cantor F.K. Central and peripheral fatigue: Exemplified by multiple sclerosis and myasthenia gravis. PM&R 2 (2010) 399-405